Skip to main content
Clinical Trials/CTRI/2022/10/046639
CTRI/2022/10/046639
Not yet recruiting
未知

Randomized control clinical trial to study the efficacy of Amrabeejadi lepa in the management of Darunaka.

Bharatiya Sanskriti Darshan Trust Ayurved Mahavidyalaya0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: L218- Other seborrheic dermatitis
Sponsor
Bharatiya Sanskriti Darshan Trust Ayurved Mahavidyalaya
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Bharatiya Sanskriti Darshan Trust Ayurved Mahavidyalaya

Eligibility Criteria

Inclusion Criteria

  • 1] Patients between age group 16 to 50 years of either gender.
  • 2] Patients having symptoms of Darunaka like Keshbhumi twaksphutan (cracking skin), Keshbhumi Kandu (itching), Keshbhumi Rukshata (dryness or roughness of scalp), Keshachyuti (hair fall).
  • 3] Patients having minimum 2\-3 or above\-mentioned symptoms.

Exclusion Criteria

  • 1] Patient with severe scalp infection like psoriasis, eczema etc.
  • 2] Patient with history of hypersensitivity.
  • 3] Patient with preexisting severe systemic diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials